ResearcherUniversity of LisbonActive in the last 2 years

B.C. Ferreira

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7988-7545; OpenAlex author ID A5031030399. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

Assessment of thein vitroradiosensitivity of pancreatic cancer cells lines using two cell survival models. Last author DOI 10.1088/1361-6560/ae7cd2 ↗
Enhanced Cytotoxicity against a Pancreatic Cancer Cell Line Combining Radiation and Gold Nanoparticles. First author DOI 10.3390/pharmaceutics16070900 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Konstantinos Outsikas · 1 shared paper, 2026 · strength 0.43
- Paper Assessment of thein vitroradiosensitivity of pancreatic cancer cells lines using two cell survival models. DOI 10.1088/1361-6560/ae7cd2 ↗
Catarina Pinto Reis · 1 shared paper, 2024 · strength 0.20
- Paper Enhanced Cytotoxicity against a Pancreatic Cancer Cell Line Combining Radiation and Gold Nanoparticles. DOI 10.3390/pharmaceutics16070900 ↗
Filipa Mendes · 1 shared paper, 2024 · strength 0.20
- Paper Enhanced Cytotoxicity against a Pancreatic Cancer Cell Line Combining Radiation and Gold Nanoparticles. DOI 10.3390/pharmaceutics16070900 ↗
Alexandra Martins · 1 shared paper, 2024 · strength 0.20
- Paper Enhanced Cytotoxicity against a Pancreatic Cancer Cell Line Combining Radiation and Gold Nanoparticles. DOI 10.3390/pharmaceutics16070900 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.